ML
AMGN icon

McAdam LLC’s Amgen AMGN Stock Holding History

McAdam LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$430K Buy
1,222
+40
+3% +$14.3K 0.02% 266
2025
Q4 		$387K Buy
1,182
+9
+0.8% +$2.85K 0.02% 284
2025
Q3 		$331K Sell
1,173
-221
-16% -$64.1K 0.02% 289
2025
Q2 		$389K Buy
1,394
+529
+61% +$150K 0.02% 241
2025
Q1 		$270K Buy
865
+9
+1% +$2.66K 0.02% 277
2024
Q4 		$223K Buy
856
+48
+6% +$14.2K 0.01% 323
2024
Q3 		$260K Sell
808
-2
-0.2% -$654 0.01% 281
2024
Q2 		$253K Buy
810
+60
+8% +$17.6K 0.02% 266
2024
Q1 		$213K Buy
750
+28
+4% +$8.19K 0.01% 280
2023
Q4 		$208K Buy
+722
New +$197K 0.02% 263
2023
Q3 		– Sell
-1,592
Closed -$353K – 261
2023
Q2 		$353K Buy
+1,592
New +$369K 0.03% 184
2018
Q4 		– Sell
-353
Closed -$73K – 84
2018
Q3 		$73K Hold
353
– – 0.03% 136
2018
Q2 		$65K Buy
353
+33
+10% +$5.84K 0.03% 127
2018
Q1 		$55K Buy
+320
New +$58.7K 0.03% 144

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

McAdam LLC's AMGN Position: Q1 2026 in Review

McAdam LLC increased its Amgen (AMGN) stake by 3.4% in Q1 2026, buying an estimated $14.3K and bringing the position to 1,222 shares worth $430K. The position accounts for 0.02% of the portfolio, ranked #266.

McAdam LLC first reported a position in AMGN in Q1 2018 and has held it in 14 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • McAdam LLC held 1,222 shares of Amgen worth $430K as of Q1 2026.
  • McAdam LLC bought 40 Amgen shares in Q1 2026, an estimated $14.3K.
  • Amgen made up 0.02% of McAdam LLC's portfolio in Q1 2026, its #266 holding.
  • McAdam LLC first reported a position in Amgen in Q1 2018 and has held it in 14 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on McAdam LLC's 13F filing for Q1 2026, filed 8 May 2026.